Varex Imaging Corporation (VREX) Financial Analysis & Valuation | Quarter Chart
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image... more
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $777.59M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Sunny S. Sanyal |
| IPO Date | 2017-01-23 | CAGR | 1.95% |
| Employees | 2,500 | Website | www.vareximaging.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
VREX chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $720.97M | P/E | 19.44 | Forward P/E | 17.23 | PEG | — |
| P/S | 0.91 | P/B | 1.59 | P/CF | 70.25 | P/FCF | -39.27 |
| Sales | $865.00M | Sales 1Y | 5.31% | Sales 3Y | -3.61% | Sales 5Y | 13.55% |
| EPS | $0.95 | EPS 1Y | -116.1% | EPS 3Y | -22.47% | EPS 5Y | -219.18% |
| Sales QoQ | -2.55% | EPS QoQ | -294.74% | Sales QoQ Avg | 1.21% | EPS QoQ Avg | -234.68% |
| Gross Margin | 34.32% | Operating Margin | 8.35% | Profit Margin | 2.55% | ROCE | 7.91% |
| ROA | 2% | ROE | 5% | Altman Z Score | 2.27 | Piotroski Score | 6 |
| Current Ratio | 3.38 | Quick Ratio | 1.53 | Cash Ratio | 0.53 | Op. CF Ratio | 0.11 |
| Debt/Equity | 0.75 | Debt/Assets | 0.34 | Lt Debt/Equity | 0.71 | Lt Debt/Cap. | 0.4 |
| Intrst Cov. | 1.86 | Inventory Turnover | 1.64 | Asset Turnover | 0.79 | Receivables Turnover | 5.98 |
| Enterprise Value | $720.97M | P/E Ratio | 19.44 |
| Forward P/E | 17.23 | PEG Ratio | — |
| P/S Ratio | 0.91 | P/B Ratio | 1.59 |
| P/CF Ratio | 70.25 | P/FCF Ratio | -39.27 |
| EPS | $0.95 | EPS Growth 1Y | -116.1% |
| EPS Growth 3Y | -22.47% | EPS Growth 5Y | -219.18% |
| Revenue Growth 1Y | 5.31% | Gross Margin | 34.32% |
| Operating Margin | 8.35% | Profit Margin | 2.55% |
| ROE | 5% | ROA | 2% |
| ROCE | 7.91% | Current Ratio | 3.38 |
| Quick Ratio | 1.53 | Cash Ratio | 0.53 |
| Debt/Equity | 0.75 | Interest Coverage | 1.86 |
| Altman Z Score | 2.27 | Piotroski Score | 6 |
Varex Imaging Corporation (VREX) valuation & financials
Varex Imaging Corporation (VREX) has a market capitalization of $777.59M and trades at a price-to-earnings ratio of 19.4. It operates in the Healthcare sector (Medical - Devices).
Varex Imaging Corporation's revenue grew +5.3% over the last year.
Varex Imaging Corporation's next earnings report is scheduled for November 17, 2026 before market open (provider scheduled date); analysts estimate EPS of $0.33. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)